Literature DB >> 15678922

Descriptive epidemiology of amyotrophic lateral sclerosis in Japan, 1995-2001.

Kazushi Okamoto1, Gen Kobashi, Masakazu Washio, Satoshi Sasaki, Tetsuji Yokoyama, Yoshihiro Miyake, Naomasa Sakamoto, Heizo Tanaka, Yutaka Inaba.   

Abstract

BACKGROUND: This study was conducted to describe the epidemiologic features of amyotrophic lateral sclerosis (ALS) in Japan by examining annual trends in mortality (1995-2001), and to discuss the background factors possibly responsible for the recent variations in the mortality rate.
METHODS: Trends in both the age-adjusted and age-specific mortality rates of ALS were examined by using the data obtained from the vital statistics of Japan between 1995 and 2001.
RESULTS: There were small increases in the number of ALS deaths (from 1249 to 1400 per year) and the crude mortality rates (from 1.00 to 1.10 per 100,000 population) between 1995 and 2001. The age-adjusted mortality rate of ALS (adjusted using the 1985 model population of Japan) has decreased (from 0.84 per 100,000 population in 1995 to 0.74 in 2001). Age-specific mortality rates have been increasing particularly in the population older than 70 years of age, with the peak in mortality in the 70- to 80-year old age group.
CONCLUSIONS: ALS mortality rates increased proportionally more for elderly population during the study period. Further epidemiologic studies will be needed to clarify the possible background factors contributing to the increase in ALS mortality in the elderly.

Entities:  

Mesh:

Year:  2005        PMID: 15678922     DOI: 10.2188/jea.15.20

Source DB:  PubMed          Journal:  J Epidemiol        ISSN: 0917-5040            Impact factor:   3.211


  7 in total

1.  Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997-2011.

Authors:  Kim Traxinger; Crystal Kelly; Brent A Johnson; Robert H Lyles; Jonathan D Glass
Journal:  Neurol Clin Pract       Date:  2013-08

Review 2.  Risk factors for amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Per M Roos; Fredrik Piehl; Freya Kamel; Fang Fang
Journal:  Clin Epidemiol       Date:  2015-02-12       Impact factor: 4.790

3.  Aspirin use associated with amyotrophic lateral sclerosis: a total population-based case-control study.

Authors:  Ching-Piao Tsai; Feng-Cheng Lin; Johnny Kuang-Wu Lee; Charles Tzu-Chi Lee
Journal:  J Epidemiol       Date:  2014-12-27       Impact factor: 3.211

4.  Anaesthesia for ophthalmologic surgical procedures in a patient with advanced amyotrophic lateral sclerosis: a case report.

Authors:  Maciej M Kowalik; Tomasz Smiatacz; Robert Pajuro; Roman Skowroński; Hanna Trocha; Walenty Nyka; Krystyna Raczyńska; Maria Wujtewicz
Journal:  Cases J       Date:  2008-11-20

5.  Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan.

Authors:  Charles Tzu-Chi Lee; Yi-Wen Chiu; Kai-Chen Wang; Chi-Shin Hwang; Kuan-Hsiang Lin; I-Ta Lee; Ching-Piao Tsai
Journal:  J Epidemiol       Date:  2012-10-27       Impact factor: 3.211

6.  Underlying cause and place of death among patients with amyotrophic lateral sclerosis in Taiwan: a population-based study, 2003-2008.

Authors:  Ching-Piao Tsai; Bo-Hsiung Chang; Charles Tzu-Chi Lee
Journal:  J Epidemiol       Date:  2013-08-10       Impact factor: 3.211

7.  A Temporal Association between Accumulated Petrol (Gasoline) Lead Emissions and Motor Neuron Disease in Australia.

Authors:  Mark A S Laidlaw; Dominic B Rowe; Andrew S Ball; Howard W Mielke
Journal:  Int J Environ Res Public Health       Date:  2015-12-19       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.